PLEKHM3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.802630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.253000E-01
Normal-vs-Stage2
7.967900E-02
Normal-vs-Stage3
6.467600E-02
Normal-vs-Stage4
5.994200E-01
Stage1-vs-Stage2
1.613820E-01
Stage1-vs-Stage3
8.638300E-02
Stage1-vs-Stage4
8.735000E-01
Stage2-vs-Stage3
3.05889999996367E-08
Stage2-vs-Stage4
1.581200E-01
Stage3-vs-Stage4
3.776000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.011000E-01
Normal-vs-AfricanAmerican
2.073800E-01
Normal-vs-Asian
8.817700E-02
Caucasian-vs-AfricanAmerican
7.915800E-01
Caucasian-vs-Asian
2.237600E-01
AfricanAmerican-vs-Asian
2.935600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.296990E-01
Normal-vs-Female
2.638000E-01
Male-vs-Female
4.067000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.267000E-01
Normal-vs-Age(41-60Yrs)
2.697400E-01
Normal-vs-Age(61-80Yrs)
1.830430E-01
Normal-vs-Age(81-100Yrs)
8.760000E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.075000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.100400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.479960E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.228360E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.513700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.788210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.484200E-02
Normal-vs-Daily Drinker
2.503900E-02
Normal-vs-Weekly Drinker
3.676400E-02
Normal-vs-Occasional Drinker
5.942200E-01
Normal-vs-Social Drinker
5.302000E-01
Non Drinker-vs-Daily Drinker
7.288800E-01
Non Drinker-vs-Weekly Drinker
7.141600E-01
Non Drinker-vs-Occasional Drinker
1.312800E-01
Non Drinker-vs-Social Drinker
1.997950E-01
Daily Drinker-vs-Weekly Drinker
9.390800E-01
Daily Drinker-vs-Occasional Drinker
1.827820E-01
Daily Drinker-vs-Social Drinker
2.660000E-01
Weekly Drinker-vs-Occasional Drinker
2.136800E-01
Weekly Drinker-vs-Social Drinker
3.007000E-01
Occasional Drinker-vs-Social Drinker
8.948800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.002420E-01
Normal-vs-Grade 2
2.530300E-02
Normal-vs-Grade 3
1.753760E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.561800E-01
Grade 1-vs-Grade 3
2.613200E-01
Grade 1-vs-Grade 4
1.002420E-01
Grade 2-vs-Grade 3
4.776400E-01
Grade 2-vs-Grade 4
2.530300E-02
Grade 3-vs-Grade 4
1.753760E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.474100E-02
Normal-vs-NonDiabetic
1.675440E-01
Diabetic-vs-NonDiabetic
7.933400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.683020E-01
Normal-vs-NoPancreatitis
1.608440E-01
Pancreatitis-vs-NoPancreatitis
9.474200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.039400E-01
Normal-vs-N1
8.638300E-02
N0-vs-N1
3.320400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.716000E-02
Normal-vs-TP53-NonMutant
6.222600E-01
TP53-Mutant-vs-TP53-NonMutant
6.183800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
